London Stock Exchange
The Company's primary listing and ordinary shares are admitted to the Official List of the London Stock Exchange. Hikma's relevant listing is under:
EPIC: HIK, SEDOL: B0LCW08 GB, ISIN: GB00B0LCW083. Further information on this market, its trading systems and current trading in Hikma's shares can be found on the London Stock Exchange website which can be accessed at: www.londonstockexchange.com
ADR programme
Hikma Pharmaceuticals PLC has an American Depositary Receipt ("ADR") programme for which Bank of New York Mellon acts as Depositary. One ADR equates to 2 Hikma ordinary shares. ADRs are traded as a Level 1 Over-The-Counter ("OTC") programme under the symbol HKMPY. Enquiries should be made to:
BNY Mellon Shareowner Services
PO Box 358516
Pittsburgh, PA 15252-8516
Telephone: +1 201 680 6825
Telephone: +1 888 BNY ADRS (toll-free within the US)
Email: shrrelations@bnymellon.com
GDR information
The Company also has listed Global Depositary Receipts (“GDRs”) on NASDAQ Dubai for which Citibank acts as Depositary. They are listed under EPIC – HIK and ISIN – US4312882081. Enquiries should be made to:
Citibank N.A. GDR Depositary Bank
Citibank Shareholder Services
Address: P.O. Box 43077, Providence,
Rhode Island 02940-3077, US
Telephone: 1 877 CITI ADR (toll-free)
Telephone: 1 781 575 4555 (out of US)
Email: citibank@shareholders-online.com
Further information on NASDAQ Dubai, its trading systems and current trading in Hikma Pharmaceuticals PLC GDRs can be found on the website www.nasdaqdubai.com